Starpharma Holdings (ASX:SPL) Receipts from Customers : A$15.66 Mil (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Starpharma Holdings Receipts from Customers?

Starpharma Holdings's Receipts from Customers for the six months ended in Dec. 2023 was A$7.00 Mil.

Starpharma Holdings's Receipts from Customers for the trailing twelve months (TTM) ended in Dec. 2023 was A$15.66 Mil.

Starpharma Holdings Receipts from Customers Historical Data

The historical data trend for Starpharma Holdings's Receipts from Customers can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Receipts from Customers Chart

Starpharma Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Receipts from Customers

Get a 7-Day Free Trial

2.81

7.23

2.44

4.85

10.23

Starpharma Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Receipts from Customers	Get a 7-Day Free Trial															1.73	3.12	1.57	8.66	7.00

Starpharma Holdings Receipts from Customers Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Receipts from Customers represents payment received from customers in the direct cash flow method.

Receipts from Customers for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$15.66 Mil.

Starpharma Holdings Receipts from Customers Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Receipts from Customers provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings (ASX:SPL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (ASX:SPL) » Definitions » Receipts from Customers

Comparable Companies

Traded in Other Exchanges

SPHRY:USA SPHRF:USA PQ6:Germany

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

Starpharma Holdings (ASX:SPL) Headlines

No Headlines